Daan van Well - 19 May 2026 Form 4 Insider Report for SOPHiA GENETICS SA (SOPH)

Reporting relationship: Chief Legal Officer
Issuer ticker: SOPH
Reported as of: 19 May 2026
Net transaction value: -$3,149
SEC form: 4
Accepted by SEC: 20 May 2026, 16:02:36 UTC
Prior SEC filing: 21 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Elimara Brunetto as Attorney-in-Fact for Daan van Well

Key filing fact

Daan van Well filed Form 4 for SOPHiA GENETICS SA (SOPH) on 20 May 2026.

Key facts

This page summarizes Daan van Well's Form 4 filing for SOPHiA GENETICS SA (SOPH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 May 2026, 16:02.

Change

Previous filing in this sequence was filed on 21 Apr 2026.
Current net transaction value: -$3,149.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002006414 Primary reporting owner

Van Well Daan

Relationship: Chief Legal Officer
Address: C/O SOPHIA GENETICS SA, LA PIECE 12, ROLLE, SWITZERLAND
Signature: /s/ Elimara Brunetto as Attorney-in-Fact for Daan van Well
Signature date: 20 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SOPH transaction

Ordinary Shares

Sale

Transaction value: $3,149
Shares: -684
Change %: -0.2%
Price: $4.60
Shares after: 345,052
Date: 19 May 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.